Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06180876
Status:
RECRUITING
Last Update Posted:
2023-12-26
First Post:
2022-06-28
Brief Title:
Effect of Remimazolam on Postoperative Delirium
Sponsor:
Zhihong LU
Organization:
Air Force Military Medical University China
Study Overview
Official Title:
Effect of General Anesthesia With Remimazolam Versus Propofol on Postoperative Delirium in Elderly Patients
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RED
Brief Summary:
Remimazolam is a novel benzodiazepine with ultra-short onset and offset of its effect It can be used for general anesthesia However classical benzodiazepine such as midazolam was reported to increase the risk of postoperative delirium Thus the investigators aim to investigate the effect of remimazolam general anesthesia on postoperative delirium in elderly patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None